Research Output
Correction: Elsherbeny et al. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation. Life 2022, 12, 876
  In the original publication [1], reference number 26 [2] was added by mistake. Thus, it was removed.

With this correction, the order of some references has been adjusted accordingly. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

  • Type:

    Other

  • Date:

    22 March 2024

  • Publication Status:

    Published

  • Publisher

    MDPI AG

  • DOI:

    10.3390/life14040423

  • Funders:

    Korea Institute of Science and Technology

Citation

Elsherbeny, M. H., Ammar, U. M., Abdellattif, M. H., Abourehab, M. A. S., Abdeen, A., Ibrahim, S. F., …Elkamhawy, A. (2024). Correction: Elsherbeny et al. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation. Life 2022, 12, 876. Life, 14(4), 423. https://doi.org/10.3390/life14040423

Authors

Keywords

quinazoline; Aurora A; kinases; anticancer; molecular docking; cell cycle; apoptosis

Monthly Views:

Available Documents